Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CO Providers > Pulmonologists

Dr. Michael Ephraim Wechsler, MD, MMSc

(Michael E. Wechsler, MD, MMSc)

(No ratings)

Specializes in: Pulmonology (Lung & Respiratory Disease) and General Practice

McGill University School of Medicine, Montreal, Quebec (1993)

1400 JACKSON STREET
Denver, CO 80206

1-877-359-0396

Dr. Michael Ephraim Wechsler, MD, MMSc is a pulmonologist in Denver, CO specializing in pulmonology (lung & respiratory disease) and general practice. He graduated from McGill University School of Medicine, Montreal, Quebec in 1993 and has 32 years of experience. Dr. Michael Ephraim Wechsler, MD, MMSc is affiliated with National Jewish Health and Main Campus.

Office Locations

Address:

1400 JACKSON STREET
Denver, CO 80206

Address:

1375 E. 19th Avenue
Denver, CO 80218

In The News (see more mentions in the news)

“While the study attempted to identify risk factors and markers that may indicate long COVID-19, doctors are finding it can happen to anyone at any age, said Dr. Michael Wechsler, a pulmonologist at...”—"These symptoms and risk factors may predict whether you could become a 'COVID-19 long hauler,' study suggests", USA Today, March 2021

“"In recent years, we've recognized that everyone's asthma is a little different, with different underlying mechanisms, and the paradigm for treating it has changed completely," said Dr. Michael...”—"There's No 'One Size Fits All' Treatment for Asthma", New York Times, February 2021

“Socioeconomic factors, such as work, can prevent them from social distancing as health officials recommend, said Dr. Michael Wechsler, professor of medicine and director of the asthma program at...”—"Denver Health testing data shows which neighborhoods have highest coronavirus infection rates", The Denver Post, April 2020

hospital care	61
inpatient care	61

**Gender**
Male	46
Female	33

**Ethnicity**
Non-Hispanic White	52
Black	14
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	29
From 75 to 84	26
85 and over	0
Less than 65	0

Hypertension	71
High Cholesterol	53
Stroke	15
Ischemic Heart Disease	51
Depression	41
Chronic Kidney Disease	71
Asthma	25
Osteoperosis	0
Atrial Fibrilation	25
Heart Failure	48
Chronic Obstructive Pulmonary Disease	34
Diabetes	47
Dementia	33
Cancer	0

hospital care	21
inpatient care	21

**Gender**
Male	36
Female	41

**Age**
From 65 to 74	30
From 75 to 84	30
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	58
Stroke	21
Ischemic Heart Disease	61
Depression	29
Chronic Kidney Disease	47
Asthma	25
Osteoperosis	14
Atrial Fibrilation	25
Heart Failure	40
Chronic Obstructive Pulmonary Disease	38
Diabetes	32
Dementia	23
Cancer	21

hospital care	16
inpatient care	16

**Gender**
Male	70
Female	70

**Ethnicity**
Non-Hispanic White	114
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	52
From 75 to 84	0
85 and over	0
Less than 65	44

Hypertension	75
High Cholesterol	50
Stroke	30
Ischemic Heart Disease	40
Depression	46
Chronic Kidney Disease	44
Asthma	39
Osteoperosis	0
Atrial Fibrilation	23
Heart Failure	29
Chronic Obstructive Pulmonary Disease	39
Diabetes	31
Dementia	0
Cancer	0

**Gender**
Male	37
Female	46

**Ethnicity**
Non-Hispanic White	68
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	35
From 75 to 84	24
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	60
Stroke	34
Ischemic Heart Disease	45
Depression	37
Chronic Kidney Disease	48
Asthma	49
Osteoperosis	16
Atrial Fibrilation	17
Heart Failure	34
Chronic Obstructive Pulmonary Disease	37
Diabetes	33
Dementia	19
Cancer	0

doctor visit	19
hospital care	30
inpatient care	30

**Gender**
Male	46
Female	32

**Ethnicity**
Non-Hispanic White	60
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	36
From 75 to 84	22
85 and over	0
Less than 65	0

Hypertension	75
High Cholesterol	59
Stroke	27
Ischemic Heart Disease	45
Depression	45
Chronic Kidney Disease	53
Asthma	31
Osteoperosis	15
Atrial Fibrilation	26
Heart Failure	33
Chronic Obstructive Pulmonary Disease	46
Diabetes	44
Dementia	17
Cancer	15

doctor visit	53

**Gender**
Male	20
Female	22

**Age**
From 65 to 74	20
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	62
High Cholesterol	45
Stroke	0
Ischemic Heart Disease	29
Depression	0
Chronic Kidney Disease	26
Asthma	62
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	43
Diabetes	0
Dementia	0
Cancer	0

doctor visit	36

**Gender**
Male	17
Female	13

**Age**
From 65 to 74	17
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	50
High Cholesterol	40
Stroke	0
Ischemic Heart Disease	40
Depression	0
Chronic Kidney Disease	0
Asthma	75
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	43
Diabetes	0
Dementia	0
Cancer	0

doctor visit	40

**Gender**
Male	13
Female	20

**Age**
From 65 to 74	18
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	64
High Cholesterol	52
Stroke	0
Ischemic Heart Disease	39
Depression	0
Chronic Kidney Disease	0
Asthma	67
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	36
Diabetes	0
Dementia	0
Cancer	0

doctor visit	95

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Michael Ephraim Wechsler, MD, MMSc for Medicare patients.

The highest averages for the top procedures that Dr. Michael Ephraim Wechsler, MD, MMSc treated as a pulmonologist in Denver, CO were hospital care and inpatient care.

doctor visit	49
hospital care	32
inpatient care	32

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Michael Ephraim Wechsler, MD, MMSc.

**Gender**
Female	27
Male	28

**Ethnicity**
Black / African American	1
Asian / Pacific Islander	0
Non-Hispanic White	29
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
85 and over	0
75 to 84	10
Less than 65	4
65 to 74	23

Average of Total of Conditions of Medicare patients treated by Dr. Michael Ephraim Wechsler, MD, MMSc From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Michael Ephraim Wechsler, MD, MMSc treated were hypertension, high cholesterol, asthma and ischemic heart disease.

Hypertension	54
High Cholesterol	41
Stroke	12
Ischemic Heart Disease	35
Depression	19
Chronic Kidney Disease	28
Asthma	37
Osteoporosis	4
Heart Failure	18
Chronic Obstructive Pulmonary Disease	31
Diabetes	18
Atrial Fibrillation	11
Cancer	3
Dementia	9

Education & Training

Dr. Michael Ephraim Wechsler, MD, MMSc graduated from McGill University School of Medicine, Montreal, Quebec in 1993. He completed residency at Beth Israel Hospital, Boston, MA. He is certified by the Board Certification: (Recertified 2018) Basic Cardiac Life Support, certification by American Heart Association and has a state license in Colorado.

Medical School: McGill University School of Medicine, Montreal, Quebec (1993)

Residency: Beth Israel Hospital, Boston, MA (1996)

Board Certification: Board Certification: (Recertified 2018) Basic Cardiac Life Support, certification by American Heart Association (1993)

Licensed In: Colorado

Affiliations & Hospitals

Dr. Michael Ephraim Wechsler, MD, MMSc is associated with these hospitals and organizations:

National Jewish Health

Main Campus

Ratings & Reviews

Dr. Michael Ephraim Wechsler, MD, MMSc does not have any reviews yet, be the first to leave a review of Dr. Michael Ephraim Wechsler, MD, MMSc here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Michael Ephraim Wechsler, MD, MMSc. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
GlaxoSmithKline, LLC.	$467,146 NUCALA $221,106	ANORO ELLIPTA $800	ANORO $230	TRELEGY ELLIPTA $40	$244,971
AstraZeneca Pharmaceuticals LP	$461,662 TEZSPIRE $128,464	FASENRA $81,512	AIRSUPRA $21,549	SYMBICORT $11,869	BEVESPI AEROSPHERE $8,436	Other $209,831
GENZYME CORPORATION	$427,453 DUPIXENT $267,310	NO PRODUCT DISCUSSED $35,907	$124,236
SANOFI-AVENTIS U.S. LLC	$269,764 DUPIXENT $220,098	NO PRODUCT DISCUSSED $16,401	DUPILUMAB $3,877	$29,388
Regeneron Healthcare Solutions, Inc.	$257,883 DUPIXENT DUPILUMAB INJECTION $50,151	DUPIXENT $43,376	$164,356
Other	$702,722 CINQAIR $61,671	BRONCHIAL THERMOPLASTY $51,215	FASENRA $40,822	XOLAIR $33,889	RESLIZUMAB $26,339	Other $488,786

**Types of Payments**
Consulting Fee	$1,111,879
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$896,646
Travel and Lodging	$518,842
Food and Beverage	$36,891
Honoraria	$18,142
Other	$4,230

Research Payments

Dr. Michael Ephraim Wechsler, MD, MMSc has received 233 research payments totaling $951,332.

Biography

Dr. Michael Wechsler is a specialist in general practice and pulmonology (lung & respiratory disease). He attended the University of Colorado Denver School of Medicine, Harvard Medical School, and McGill University Faculty of Medicine for medical school and subsequently trained at Beth Israel Deaconess Medical Center and Boston VA Medical Center for residency. Dr. Wechsler is affiliated with National Jewish Health.